Xconomy
OCTOBER 7, 2016
military’s high-tech think tank DARPA described Safe Genes, a new program to fund safety measures that can be built into genome editing technology or counter its potential wayward effects. PRICE FIGHTS. With some caveats, ICER recommended lower prices. Shares immediately fell more than 40 percent. —The U.S.
Both Sides of the Table
JANUARY 25, 2014
He just had his Mitt Romney moment and his name will forever be etched in the collective consciousness of the tech community for this terribly insensitive and tone deaf letter to the Wall Street Journal. We have outrage over the rising real-estate prices which these “techno geeks” can pay. ”".
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Both Sides of the Table
AUGUST 30, 2010
This post was originally published in a shorter (more sensible) format in the Wall Street Journal online. The prices of angel deals have recently crept up, VCs have also gotten their checkbooks out again, frothy deals are happening and people are feeling bullish. We took $2.3
Xconomy
JUNE 3, 2016
—A team led by Jef Boeke of New York University, George Church of Harvard University, Andrew Hessel of software maker Autodesk, and Nancy Kelley proposed in the journal Science to build a synthetic human genome. The drug has a list price of $69,350 per patient, per year. To find out more, dive into this week’s roundup.
Expert insights. Personalized for you.
77 
Let's personalize your content